4.1 Article

The Effectiveness of Family History Questionnaires in Cancer Genetic Counseling

Journal

JOURNAL OF GENETIC COUNSELING
Volume 18, Issue 4, Pages 366-378

Publisher

WILEY
DOI: 10.1007/s10897-009-9228-x

Keywords

Genetic counseling; Family history; Hereditary breast and ovarian cancer; Probability estimate

Ask authors/readers for more resources

The number of individuals receiving genetic counseling for hereditary breast and ovarian cancer syndrome has steadily risen. To triage patients for genetic counseling and to help reduce the amount of time needed by a genetic counselor in direct patient contact, many clinics have implemented the use of family history questionnaires. Although such questionnaires are widely used, scant literature exists evaluating their effectiveness. This article explores the extent to which family history questionnaires are being used in Ontario and addresses the utility of such questionnaires in one familial cancer clinic. By comparing the pedigrees created from questionnaires to those updated during genetic counseling, the accuracy and effectiveness of the questionnaires was explored. Of 121 families recruited into the study, 12% acquired changes to their pedigree that led to a revised probability estimate for having a BRCA1 or BRCA2 mutation and 5% acquired changes that altered their eligibility for genetic testing. No statistically significant difference existed between the eligibility for genetic testing prior to and post counseling. This suggests that family history questionnaires can be effective at obtaining a family history and accurately assessing eligibility for genetic testing. Based on the variables that were significantly associated with a change in probability estimate, we further present recommendations for improving the clarity of such questionnaires and therefore the ease of use by patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Regulation of arsenic methylation: identification of the transcriptional region of the human AS3MT gene

Kunie Yoshinaga-Sakurai, Toby G. Rossman, Barry P. Rosen

Summary: AS3MT is a human enzyme that catalyzes arsenic biotransformations and is considered to contribute to arsenic-related diseases. The expression of AS3MT is tissue/cell type-specific, and the transcriptional regulation mechanism of the gene is still unknown. In this study, the core promoter region of the human AS3MT gene is defined, and a GC box in the promoter is identified as a site where the transcription factor Sp1 binds, indicating the involvement of regulatory elements in AS3MT gene expression.

CELL BIOLOGY AND TOXICOLOGY (2022)

Article Microbiology

Oxidation of organoarsenicals and antimonite by a novel flavin monooxygenase widely present in soil bacteria

Jun Zhang, Jian Chen, Yi-Fei Wu, Zi-Ping Wang, Ji-Guo Qiu, Xiao-Long Li, Feng Cai, Ke-Qing Xiao, Xiao-Xu Sun, Barry P. Rosen, Fang-Jie Zhao

Summary: Arsenic can be biomethylated to form various organic arsenicals with different toxicities and environmental mobilities. The trivalent methylarsenite (MAs(III)) produced in this process is more toxic than inorganic arsenite (As(III) and can also act as a primitive antibiotic. A new enzyme, ArsV, has been identified in Ensifer adhaerens ST2, which plays a role in detoxifying MAs(III) and Sb(III) by oxidizing them to MAs(V) and Sb(V). Genes encoding ArsV are widely present in soil bacteria according to metagenomic analysis.

ENVIRONMENTAL MICROBIOLOGY (2022)

Article Microbiology

Organoarsenical tolerance in Sphingobacterium wenxiniae, a bacterium isolated from activated sludge

Jian Chen, Jun Zhang, Barry P. Rosen

Summary: Organoarsenicals enter the environment from biogenic and anthropogenic sources. Microorganisms can methylate trivalent inorganic arsenite to more toxic methylarsenite and oxidize them. Sources include herbicides and antimicrobial growth promoters, with microorganisms such as Sphingobacterium wenxiniae showing resistance and detoxification abilities.

ENVIRONMENTAL MICROBIOLOGY (2022)

Review Environmental Sciences

The enigma of environmental organoarsenicals

Xi-Mei Xue, Chan Xiong, Masafumi Yoshinaga, Barry Rosen, Yong-Guan Zhu

Summary: This review summarizes the classification, identification, and toxicological properties of organoarsenicals in the environment. The toxicological properties and biological functions of most organoarsenicals are still largely unknown.

CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY (2022)

Review Biochemistry & Molecular Biology

Arsenic in medicine: past, present and future

Ngozi P. Paul, Adriana E. Galvan, Kunie Yoshinaga-Sakurai, Barry P. Rosen, Masafumi Yoshinaga

Summary: Arsenicals, one of the oldest treatments for various human disorders, have been paradoxically used as therapeutic agents since ancient times despite their toxicity. After the discovery of antibiotics, most arsenic-based drugs were abandoned, but recent years have seen a renewed interest in their clinical use. The current applications of arsenicals include antimicrobial, antiviral, antiparasitic, and anticancer uses. With the rise of antibiotic resistance and emerging pathogens, revisiting arsenicals as an effective treatment option is suggested.

BIOMETALS (2023)

Article Genetics & Heredity

The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT

Amy Finch, Kelly Metcalfe, Mohammad Akbari, Eitan Friedman, Nadine Tung, Barry Rosen, Andrea Eisen, Beth Karlan, William Foulkes, Susan L. Neuhausen, Leigha Senter, Wendy McKinnon, Christine Elser, Ping Sun, Steven A. Narod

Summary: Approximately 1% of the Ashkenazi Jewish population carries the BRCA2 6174delT pathogenic variant, which is associated with the risks of breast and ovarian cancer. Women carrying the 6174delT variant have a significantly lower annual risk for developing breast cancer compared to those carrying other variants in the BRCA2 gene, but the difference in ovarian or fallopian tube cancer risk is not significant.

CLINICAL GENETICS (2022)

Article Microbiology

Functional characterization of the methylarsenite-inducible arsRM operon from Noviherbaspirillum denitrificans HC18

Jun Zhang, Jian Chen, Yi-Fei Wu, Xia Liu, Charles Packianathan, Venkadesh S. Nadar, Barry P. Rosen, Fang-Jie Zhao

Summary: This study identified an arsRM operon in Noviherbaspirillum denitrificans HC18, which can detoxify MAs(III) via further methylation.

ENVIRONMENTAL MICROBIOLOGY (2022)

Review Medicine, General & Internal

The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS

Y. Tong, E. Orang'o, M. Nakalembe, P. Tonui, P. Itsura, K. Muthoka, M. Titus, S. Kiptoo, A. Mwangi, J. Ong'echa, R. Tonui, B. Odongo, C. Mpamani, B. Rosen, A. Moormann, S. Cu-Uvin, J. A. Bailey, C. Oduor, A. Ermel, C. Yiannoutsos, B. Musick, E. Sang, A. Ngeresa, G. Banturaki, A. Kiragga, J. Zhang, Y. Song, S. Chintala, R. Katzenellenbogen, P. Loehrer, D. R. Brown

Summary: The East Africa Consortium was established to study the epidemiology of HPV infections and cervical cancer, as well as the influence of HIV infection on HPV and cervical cancer. Collaborations between researchers in North America and East African countries have led to a better understanding of the impact of HIV infection on the detection and persistence of oncogenic HPV, the effects of dietary aflatoxin on HPV detection, the benefits of antiretroviral therapy on HPV persistence, and the differences in HPV detections among HIV-infected and HIV-uninfected women undergoing treatment for cervical dysplasia. Future research will focus on how HPV testing can be integrated into cervical cancer screening programs, the influence of aflatoxin on the immunological control of HIV, and how HPV alters certain genes involved in tumor growth in HIV-infected women.

ANNALS OF MEDICINE (2022)

Article Oncology

Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal

Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Janusz Menkiszak, Jeanna McCuaig, Kelly Metcalfe, William D. Foulkes, Susan L. Neuhausen, Sophie Sun, Beth Y. Karlan, Andrea Eisen, Nadine Tung, Olufunmilayo Olopade, Fergus J. Couch, Tomasz Huzarski, Leigha Senter, Louise Bordeleau, Christian F. Singer, Charis Eng, Robert Fruscio, Tuya Pal, Ping Sun, Steven A. Narod

Summary: The study suggests that bilateral oophorectomy is unlikely to determine the risk of breast cancer in BRCA1 mutation carriers, but it should be offered at age 35 to reduce the risk of ovarian and fallopian tube cancer.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Microbiology

ArsZ from Ensifer adhaerens ST2 is a novel methylarsenite oxidase

Jun Zhang, Yan-Ning Li, Jian Chen, Yu Yan, Barry P. Rosen, Fang-Jie Zhao

Summary: This study investigates the molecular mechanisms behind the MAs(III) resistance of Ensifer adhaerens ST2. The results show that the gene arsZ encodes a novel MAs(III) oxidase, which oxidizes highly toxic MAs(III) to relatively nontoxic MAs(V) and confers resistance.

ENVIRONMENTAL MICROBIOLOGY (2022)

Article Microbiology

Anoxygenic phototrophic arsenite oxidation by a Rhodobacter strain

Yi-Fei Wu, Jian Chen, Wan-Ying Xie, Chao Peng, Shi-Tong Tang, Barry P. P. Rosen, Andreas Kappler, Jun Zhang, Fang-Jie Zhao

Summary: We isolated a photosynthetic purple bacteria, Rhodobacter strain CZR27, from an arsenic-contaminated paddy soil and demonstrated its capacity to oxidize As(III) to As(V) using malate as a carbon source photosynthetically. Our study revealed the presence of anaerobic photosynthesis-coupled As(III) oxidation in paddy soils, highlighting the importance of light-dependent, microbe-mediated arsenic redox changes in paddy arsenic biogeochemistry.

ENVIRONMENTAL MICROBIOLOGY (2023)

Article Engineering, Environmental

Arsenite Methyltransferase Diversity and Optimization of Methylation Efficiency

Jian Chen, Barry P. Rosen

Summary: In this study, the broad diversity of structural domains in ArsMs was revealed through comparative analysis. The differences in the ArsM structure lead to variations in methylation efficiency and substrate selectivity. The C-terminal domain was found to play a role in modulating the rate of catalysis. Additionally, the relationship between arsenite efflux systems and methylation was examined.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2023)

Article Biochemistry & Molecular Biology

The ArsQ permease and transport of the antibiotic arsinothricin

Ngozi P. P. Paul, Thiruselvam Viswanathan, Jian Chen, Masafumi Yoshinaga, Barry P. P. Rosen

Summary: AST is a pentavalent organoarsenical synthesized by Burkholderia gladioli GSRB05, which is effective against carbapenem-resistant Enterobacter cloacae. It inhibits bacterial glutamine synthetase and is a non-proteogenic amino acid and glutamate mimetic. ArsQ is an efflux permease that is proposed to transport AST or related species out of the cells, but the chemical nature of the actual transport substrate is unclear.

MOLECULAR MICROBIOLOGY (2023)

Article Microbiology

Arsinothricin Inhibits Plasmodium falciparum Proliferation in Blood and Blocks Parasite Transmission to Mosquitoes

Masafumi Yoshinaga, Guodong Niu, Kunie Yoshinaga-Sakurai, Venkadesh S. S. Nadar, Xiaohong Wang, Barry P. P. Rosen, Jun Li

Summary: Malaria caused by Plasmodium parasites is a major disease with high morbidity and mortality rates. The Plasmodium parasite has a complex life cycle involving both human and mosquito hosts. Most current antimalarials only target the blood stage of the parasite, requiring the development of new drugs that can target multiple stages of the life cycle.

MICROORGANISMS (2023)

Article Engineering, Environmental

Widespread Distribution of the arsO Gene Confers Bacterial Resistance to Environmental Antimony

Shi-Tong Tang, Xin-Wei Song, Jian Chen, Jie Shen, Bin Ma, Barry P. Rosen, Jun Zhang, Fang-Jie Zhao

Summary: This study identified a previously unknown gene, arsO, which encodes an enzyme called ArsO that oxidizes Sb(III) to Sb(V) under aerobic conditions. The enzyme plays a significant role in the detoxification of Sb(III) in the environment. The arsO gene is widely distributed and abundant in various environments affected by human activities.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2023)

No Data Available